Teva to cut 315 in Irish plant wind-down

Half of Teva Pharmaceutical's workers at a Waterford, Ireland, plant are getting the axe. In the second plant-layoff announcement this week, the Israeli generics maker told workers that 315 jobs will go, via a mixture of voluntary buyouts and layoffs. The cuts will come within 12 months as Teva stops making drug tablets at the plant.

The plant won't close completely, however; the remaining workers will still turn out inhalers for Teva. And word is that the tablet production isn't going away. It's just being transferred out of Ireland to Hungary, RTÉ News reports.

Teva's job-cuts news comes on the heels of Sanofi-Aventis' announcement that it would shut down a plant in Kansas City, MO. About 370 jobs are on the line there. It's all part of pharma's ongoing efforts to cut costs and streamline production. With two megadeals nearing closure--Merck and Schering-Plough's merger, and Pfizer's buyout of Wyeth--more manufacturing cuts are sure to come.

- read the RTÉ news
- get more from Inside Ireland

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.